Antiplatelet therapies in diabetes.

Diabetic Medicine : a Journal of the British Diabetic Association
R C SagarR A Ajjan

Abstract

Cardiovascular complications remain the main cause of mortality and morbidity in diabetes. This is related to advanced vascular pathology in this population, together with an enhanced thrombotic environment. The increased risk in thrombosis is secondary to platelet hyper-reactivity and increased levels and/or altered activity of coagulation factors. The current review is focused on the role of antiplatelet agents in modulating the thrombotic milieu in diabetes and improving vascular outcome in this high-risk population. We review the latest evidence for the use of aspirin in primary vascular prevention together with long-term treatment with this agent for secondary prevention. We also discuss the effects of the various P2Y12 inhibitors, including clopidogrel, prasugrel and ticagrelor, on both short- and long-term secondary vascular prevention. Moreover, we briefly review antiplatelet therapies in special groups of people including those intolerant to aspirin, individuals with peripheral vascular disease and those with cerebrovascular pathology. The overall aim of this review is to provide the healthcare professional with a pragmatic guide for the management of thrombotic risk using established antiplatelet therapies to improve ...Continue Reading

References

Jul 20, 1989·The New England Journal of Medicine·UNKNOWN Steering Committee of the Physicians' Health Study Research Group
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Dec 2, 2005·The New England Journal of Medicine·Carlo PatronoColin Baigent
Mar 15, 2006·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHARISMA Investigators
Feb 10, 2007·European Heart Journal·Richard M CubbonUNKNOWN Evaluation of Methods and Management of Acute Coronary Events Investigators
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Feb 25, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·U BulugahapitiyaI Idris
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 18, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·S H Alzahrani, R A Ajjan
Jul 1, 2011·Expert Review of Cardiovascular Therapy·Dominick J AngiolilloAntonio Fernandez-Ortiz
Nov 15, 2011·The New England Journal of Medicine·Pierluigi TricociUNKNOWN TRACER Investigators
Oct 17, 2012·American Heart Journal·Jean-Guillaume DillingerPatrick Henry
Mar 17, 2015·The New England Journal of Medicine·Marc P BonacaUNKNOWN PEGASUS-TIMI 54 Steering Committee and Investigators
Apr 25, 2015·Circulation Research·Michael H Criqui, Victor Aboyans
Jun 5, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·M A BethelR R Holman
Apr 19, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·S K KunutsorK Khunti
Dec 14, 2016·The New England Journal of Medicine·William R HiattUNKNOWN EUCLID Trial Steering Committee and Investigators
Mar 11, 2017·Cardiovascular Diabetology·Katherine KearneyRamzi Ajjan
Aug 29, 2017·The New England Journal of Medicine·John W EikelboomUNKNOWN COMPASS Investigators
Sep 9, 2017·Journal of the American College of Cardiology·Marc P BonacaMarc S Sabatine
Jun 12, 2018·Journal of Stroke·Georgios TsivgoulisAndrei V Alexandrov
Aug 28, 2018·The New England Journal of Medicine·UNKNOWN ASCEND Study Collaborative GroupJane Armitage
Sep 18, 2018·The New England Journal of Medicine·John J McNeilUNKNOWN ASPREE Investigator Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.